Triglyceride-glucose index and the progression of chronic obstructive pulmonary disease, panvascular disease, and multimorbidity: a prospective cohort study
Open Access
- 26 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1855099
Abstract
Objective: Chronic obstructive pulmonary disease (COPD) and panvascular disease (PD) are often driven by shared risk factors. We aimed to investigate the longitudinal association of triglyceride-glucose (TyG) index with incidence of COPD, PD, and their multimorbidity. Methods: Our study used data from the UK Biobank, a population-based prospective study. Cox proportional hazards regression was used to evaluate the association between TyG index and the risk of incident COPD, panvascular disease, and their Multimorbidity. Multistate models (MSMs) were used to evaluate the longitudinal progression from healthy to incident COPD or PD, and ultimately to multimorbidity, across TyG index quartiles. Results: Among the 296,818 participants included in the final analysis, the TyG index was associated with higher incidence of COPD and PD. Each 1-SD increase in TyG index was associated with a 9% higher risk of PD (HR 1.09, 95% CI 1.05–1.12). These associations were more pronounced among females. In multistate analyses, compared with the lowest quartile, women in the highest TyG quartile had greater risks of progression from baseline to COPD (HR 1.22, 95% CI 1.04–1.43), baseline to PD (HR 1.29, 95% CI 1.19–1.39), COPD to multimorbidity (HR 2.11, 95% CI 1.32–3.37), and PD to multimorbidity (HR 3.67, 95% CI 2.00–6.72). For males, a higher TyG index was protective against COPD incidence (HR 0.79, 95% CI 0.68–0.93) but increased PD risk (HR 1.18, 95% CI 1.09–1.26), whereas no significant associations were found for other transitions. Conclusions: Elevated TyG index was associated with incident COPD and PD, while the association with multimorbidity was attenuated after full adjustment in the overall cohort. In multistate analyses, stronger and more consistent associations were observed in women, particularly for progression from single disease to multimorbidity. The TyG index may serve as a metabolic indicator that helps identify women at elevated risk and may inform targeted prevention strategies.Keywords
This publication has 31 references indexed in Scilit:
- Blood Glucose Levels, Inflammation, and Mortality in Asthmatic Populations: A Prospective Cohort StudyJournal of Epidemiology and Global Health, 2025
- Sex difference in human diseases: mechanistic insights and clinical implicationsSignal Transduction and Targeted Therapy, 2024
- The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling studyThe Lancet Global Health, 2023
- The chain mediating role of C-reactive protein and triglyceride-glucose index between lung function and cognitive function in a systemic low-grade inflammation stateJournal of Psychiatric Research, 2022
- MultimorbidityNature Reviews Disease Primers, 2022
- Association of Triglyceride-Glucose Index and Lung HealthChest, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- The association between subclinical inflammation and abnormal glucose and lipid metabolisms in normal-weight Korean individualsNutrition, Metabolism and Cardiovascular Diseases, 2018
- Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistanceEndocrine, 2018
- Gender differences in the cardiovascular effect of sex hormonesNature Reviews Cardiology, 2009